Kelatox Suppositories

Professional Grade Supplements - Kelatox Suppositories are Safe and Effective
900 mg. of EDTA-Ca
The most Powerful EDTA-Ca Chelation Therapy Available!

Home

 

- Artery Disease
- Combating Arterial Plaque
- Chelation & Heart
- Calcification in Diseases
- "Prevention & Rejuvenation" Dr. Morton
- "Chelation Answer" Dr. Morton
- Reduction in Cancer
- Cancer Research Studies
- Calcification in Diseases - Heavy Metals
- 5 Common Metals
- News Articles
- Iron and Cancer
- Contact Us
- Email Us

 

 

Kelatox Suppositories
"Removes and Improves"
Heavy Metal Detox System

 

“Why can’t I just swallow a pill?”
“Why do I have to do a suppository?”
“What are the differences between IV, suppository and oral EDTA Chelation Therapy?”

 

The answers are pretty simple and logical...

EDTA is a synthetic amino acid and must be introduced directly into the bloodstream for maximum effectiveness. EDTA when taken orally must pass through the gastro intestinal system where the acid and enzymes in the stomach and intestine will cause the EDTA to break down and not be properly absorbed. This is why EDTA therapy has been more successful when administered by IV over the oral route of administration.
Suppositories provide the same results as the IV without the needle since the EDTA is absorbed by the colon wall and placed directly into the bloodstream just as an IV treatment would. Kelatox suppositories are given at a lower dose than the IV which lowers the risk of complications with liver and kidney function and are safe enough to be given daily, thus increasing the amount of EDTA in the bloodstream at any given moment making the suppository method more effective over time.

 
Oral (Mouth)
Intravenous (IV or needle)
Suppository (Rectal)
Requires MD
No
Yes
No
Requires blood tests
No
Yes
No
Requires liver and kidney function tests
No
Yes
No
Typical absorption
5%
100%
95%
Dosage
300mg
2 Grams
900mg
Average cost per dosage/day
$0.69 (recommended 3 capsules daily)
$125
$7.30
Dosages required to equal 1 IV
200 capsules
1 IV treatment
2.49 suppositories
Cost equivalent to 1 IV
$34.50
$125.00
$21.90
Cost per 15 Treatments
$517.50
$1,875.00
$199.00
Time to administer dose
As long as it takes to swallow 200 Capsules
2-3 hours
about a minute
Recommended treatment
1 treatment per month X 2 1/2 years equals 30 treatments
30 treatments
90 suppositories equals 30 treatments
Recommended Maintenance (equal 1 IV)
200 capsules monthly
1 treatment monthly
3 suppositories monthly
(1 box last 10 months)
This
is
the
Bottomline
Total Cost (based on 30 IV treatments)
$1,035.00
$3,750.00
$398.00

* These are estimates. There is no way to accurately ascertain exact equivalents.


Intravenous EDTA chelation therapy has been proven safe and effective as a treatment for coronary heart disease, atherosclerosis and other age-related diseases. The downside of intravenous therapy is you still need blood tests plus liver and kidney function tests before you can begin the treatment to ensure your safety. Dozens of scientific studies spanning 50 years prove that intravenous EDTA safely increases blood flow, alleviates symptoms of cardiovascular disease as well as removes heavy metals. Over the past decade, the suppository method of EDTA therapy has emerged which as virtually equal to the intravenous method on any medical level. Because the EDTA is absorbed through the colon and goes directly into the blood stream thereby bypassing the liver and kidneys on the first pass, suppositories provide the same benefits of intravenous ETDA therapy, though it requires roughly three suppositories to equal one intravenous treatment. The upside to the suppository method is it is a fraction of the cost of intravenous therapy.

In regards to oral EDTA therapy, there are no scientific studies of any kind, to date, showing similar benefit using EDTA by mouth. Plus there's good reason to believe that prolonged use of high-dose oral EDTA may be harmful. First and foremost, EDTA is very poorly absorbed by mouth—only about five percent. It is theoretically possible to slowly absorb a substantial amount of EDTA by mouth over a prolonged period of time and receive some benefit but there could be potential problems with that approach:


The unabsorbed 95 percent of EDTA remains within the digestive tract, mixing with undigested food and nutrients while passing on out of the body in stool. This unabsorbed EDTA tightly binds to and blocks absorption of many essential nutritional trace elements as it passes through the gastro intestinal tract. It blocks the uptake of zinc, manganese, chromium, vanadium, copper, chromium, molybdenum and other essential nutrients, potentially causing deficiencies.

Both the suppository and IV administration of EDTA have been proven safe since they will both deliver a greater dosage per application than oral EDTA thus delivering greater benefits in a much shorter period of time than oral EDTA. Mineral supplementation is essential when using EDTA, but you should separate it from using EDTA by at least 8 hours so you do not remove what you are trying to replace. It is normally recommended to utilize Oral EDTA 3 times daily, this time frame would not give your body ample time to breakdown and process your mineral supplementation before the EDTA would bind with the minerals and remove them from your body.

Intravenous and suppository EDTA therapy results in high therapeutic blood levels. EDTA by mouth results in very low blood levels subsequently resulting in little proven benefit for treatment of heavy metal removal or cardiovascular disease.
Daily use of EDTA by mouth may cause progressive deficiencies of zinc, manganese and other essential trace nutrients, which are an essential part of the body's antioxidant defenses. For example, superoxide dismutase (SOD), a very important intracellular antioxidant, cannot function without zinc and manganese. By inactivating antioxidant enzymes, daily EDTA by mouth actually worsens the very problems supposedly being treated.

Since EDTA remains outside of the cell wall and oral EDTA produces only a low concentration at cell surfaces throughout the body it will only pull out through diffusion a small quantity of toxic heavy metals from inside cells. Conversely, the intravenous and suppository method result in much higher levels giving the EDTA a much better opportunity to function properly.

Additionally, EDTA by mouth will not produce a pulsitile release of parathormone that is associated with intravenous or suppository chelation therapy. If that mechanism of action is important to achieve benefit, it will not occur with oral EDTA.

 

 

 

Kelatox is a rectal, time released suppository with added anti oxidants that bind and remove harmful heavy metals from your body while supplying added nutrients. Kelatox brand of suppositories use 900 mg of Calcium Disodium EDTA in a Cocoa Butter base with methocel E4M premium USP for a time release effect. Each suppository will dissolve through body heat and gradually spread over the lining of the colon and be absorbed directly into the blood stream in approximately 90-120 minutes.

EDTA is a synthetic amino acid first manufactured in the 1940's that has proven to be the best broad based heavy metal chelator with very few adverse effects. The half life of EDTA is 20-60 minutes and is excreted primarily by the kidneys within 24 hours but may also be excreted through the bowels. Almost none of the EDTA is metabolized. Since the vast majority of the EDTA will be broken down and not utilized while taken orally, the rectal route of administration is very effective. By using suppositories, the EDTA bypasses the gastro-intestinal tract which means very little will be destroyed by the acids and enzymes in the GI tract allowing for a very high utilization rate. Also, by using a suppository a majority of the EDTA will bypass the liver and kidneys on first pass putting less stress on those organs and allowing the EDTA plus anti-oxidants to remain in the body longer giving it a better chance to bind with harmful metals.

 

These products are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. The information is designed for educational purposes only and is not intended to be prescriptive. Should you require advice for any particular health reason it is advised that you consult your health care provider.

Copyright 2006: kelatoxChelation.com | All Rights Reserved

Keywords to Remember: diseases, Calcification Diseases, Chelation Therapy, Chelation Therapy, Chelation, heart disease, heart, Kidney Stones, kidneys disease, PKD, kidneys, atherosclerosis, coronary artery plaque, plaque, artery plaque,coronary plaque, HIV, ovarian cancer, ovarian, cancer, kidney cysts, Prostatitis, Diabetes, Arthritic spurs, Cataracts, Scleroderma, breast pathology, diseases, Calcification Diseases, Chelation Therapy, Chelation, heart disease, heart, Kidney Stones, kidneys disease, PKD, kidneys, atherosclerosis, coronary artery plaque, plaque, artery plaque,coronary plaque, HIV, ovarian cancer, ovarian, cancer, kidney cysts, Prostatitis, Diabetes, Arthritic spurs, Cataracts, Scleroderma, breast pathology, kelatox